A cost-effectiveness analysis of erthropoietin in ICU patients

PD Levin, Robert Fowler, David Naimark

Critical Care · 2004 · 261 citations · 38 references

DOIFull text

Open access

Concepts

Abstract

Recombinant human erythropoietin (rhEPO) has been shown to decrease the packed red blood cell (PRBC) transfusion requirement by about 20% among ICU patients admitted for longer than 48 hours. Despite this, its use has not been widely instituted, in part due to its cost.

References

38